Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 9/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | PDE4A | P27815 | 1/20 | 0.67 |
| ▸ | KDR | P35968 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | CCR2 | P41597 | 1/20 | 0.35 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4287153 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A | |
| SCHEMBL22199 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A | |
| SCHEMBL33477 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A | |
| SCHEMBL8503965 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A | |
| SCHEMBL3998680 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A | |
| SCHEMBL18585750 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A | |
| SCHEMBL576838 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A | |
| SCHEMBL9947670 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A | |
| SCHEMBL577659 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A | |
| SCHEMBL935211 | 1.00 | CXCR4 (1.00) | CXCR4SMN1; SMN2HIF1AMAPTPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11525074-B2 | Two-component curing adhesive, laminated film, laminated film-manufacturing apparatus, and method for manufacturing laminated film | DIC CORPORATION (JP) | 2022-12-13 | — | — | US | claimed |
| EP-4397492-A1 | ADHESIVE, LAYERED BODY, METHOD FOR MANUFACTURING LAYERED BODY, AND PACKAGING MATERIAL | DIC Corporation (JP) | 2024-07-10 | — | — | EP | disclosed |
| CN-118234771-A | Adhesive, laminate, and packaging material | DIC株式会社 | 2024-06-21 | — | — | CN | disclosed |
| CN-118234824-A | Adhesive, laminate, method for producing laminate, and packaging material | DIC株式会社 | 2024-06-21 | — | — | CN | disclosed |
| WO-2024095572-A1 | COATING COMPOSITION AND COATING FILM | 日本ペイント・インダストリアルコーティングス株式会社 | 2024-05-10 | — | — | WO | disclosed |
| CN-117730130-A | Adhesive, laminate, method for producing laminate, and packaging material | DIC株式会社 | 2024-03-19 | — | — | CN | disclosed |
| CN-117715999-A | Adhesive, laminate, method for producing laminate, and packaging material | DIC株式会社 | 2024-03-15 | — | — | CN | disclosed |
| EP-2966135-B1 | ANTICORROSIVE COATING COMPOSITION, ANTICORROSIVE COATING FILM, AND METHOD FOR PREVENTING CORROSION OF BASE MATERIAL | CHUGOKU MARINE PAINTS (JP) | 2024-02-21 | — | — | EP | disclosed |
| CN-117043289-A | Coating composition | 日涂工业涂料有限公司 | 2023-11-10 | — | — | CN | disclosed |
| EP-3385072-B1 | ANTIFOULING COMPOSITE COATING FILM, ANTIFOULING SUBSTRATE, AND METHOD FOR MANUFACTURING ANTIFOULING SUBSTRATE | CHUGOKU MARINE PAINTS (JP) | 2023-09-06 | — | — | EP | disclosed |
| EP-1689393-A2 | PREPARATION OF 1,7-DISUBSTITUTED AZABENZIMIDAZOLES AS KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2006-08-16 | — | — | EP | disclosed |
| US-20050197328-A1 | Imidazopyridine derivatives as kinase inhibitors | GLAXO GROUP LIMITED (GB) | 2005-09-08 | — | — | US | disclosed |
| US-20050153978-A1 | Medicaments | GLAXO GROUP LIMITED (GB) | 2005-07-14 | — | — | US | disclosed |
| WO-2005037198-A2 | PREPARATION OF 1,7-DISUBSTITUTED AZABENZIMIDAZOLES AS KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2005-04-28 | — | — | WO | disclosed |
| EP-1490367-A1 | IMIDAZOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2004-12-29 | — | — | EP | disclosed |
| EP-1487441-A2 | BENZIMIDAZOLES AND THEIR USE AS MITOGEN-ACTIVATED- AND RHO-KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003080610-A1 | IMIDAZOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2003-10-02 | — | — | WO | disclosed |
| WO-2003080125-A2 | BENZIMIDAZOLES AND THEIR USE AS MITOGEN-ACTIVATED- AND RHO-KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2003-10-02 | — | — | WO | disclosed |
| US-20020165221-A1 | Mediators of hedgehog signaling pathways, compositions and uses related thereto | CURIS, INC. | 2002-11-07 | — | — | US | disclosed |
| US-3950451-A | COUPLED PRODUCT OF ALKYLPHENOL AND PHENOL-FORMALDEHYDE-DIAMINE CONDENSATE | ASAHI DENKA KOGYO K.K. (JA) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197328-A1 | Imidazopyridine derivatives as kinase inhibitors | NR4A3, XDH, MAPK8 | CXCR4 124/4885SMN1; SMN2 3075/4885HIF1A 1362/4885 |
| US-20050153978-A1 | Medicaments | GRK1, ROCK1, GRK7 | CXCR4 976/4885SMN1; SMN2 1495/4885HIF1A 2156/4885 |
| US-20020165221-A1 | Mediators of hedgehog signaling pathways, compositions and uses related thereto | SHH, SMO, GLI1 | CXCR4 1591/4885SMN1; SMN2 4587/4885HIF1A 871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.